Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA1A | P0DMV8 | 1/20 | 0.46 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | USP2 | O75604 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.39 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.39 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14946822 | 0.91 | KMT2A (0.43) | HSPA1APABPC1ALDH1A1NPSR1MGLL | |
| SCHEMBL2550420 | 0.84 | HSPA1A (0.52) | HSPA1APABPC1ALDH1A1NPSR1MGLL | |
| SCHEMBL12748846 | 0.74 | DPP8 (0.50) | HSPA1APABPC1ALDH1A1NPSR1MGLL | |
| SCHEMBL10834888 | 0.73 | MGLL (0.52) | HSPA1APABPC1ALDH1A1NPSR1MGLL | |
| SCHEMBL8846028 | 0.73 | HSPA1A (0.45) | HSPA1APABPC1ALDH1A1NPSR1MGLL | |
| SCHEMBL12748820 | 0.73 | JUN (0.42) | KMT2AMEN1CES2DPP8 | |
| SCHEMBL7941692 | 0.73 | HSPA1A (0.41) | HSPA1APABPC1ALDH1A1NPSR1POLB | |
| SCHEMBL12748800 | 0.72 | ANPEP (0.33) | — | |
| SCHEMBL16280099 | 0.72 | MGLL (0.62) | HSPA1APABPC1ALDH1A1NPSR1MGLL | |
| SCHEMBL27622789 | 0.71 | HSP90AA1 (0.42) | HSPA1APABPC1ALDH1A1NPSR1MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2181172-B1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2016-02-24 | — | — | EP | disclosed |
| US-20140155603-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2014-06-05 | — | — | US | disclosed |
| US-20140155603-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2014-06-05 | — | — | US | disclosed |
| US-8674104-B2 | Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof | BASF SE (DE) | 2014-03-18 | — | — | US | disclosed |
| US-8674104-B2 | Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof | BASF SE (DE) | 2014-03-18 | — | — | US | disclosed |
| US-20130123495-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | CLAP CO., LTD. (KR) | 2013-05-16 | — | — | US | disclosed |
| US-20130123495-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | CLAP CO., LTD. (KR) | 2013-05-16 | — | — | US | disclosed |
| US-20110068328-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2011-03-24 | — | — | US | disclosed |
| US-20110068328-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2011-03-24 | — | — | US | disclosed |
| WO-2009024512-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2009-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110068328-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | NR0B1, NR0B2, RXRB | HSPA1A 2480/4885PABPC1 4422/4885ALDH1A1 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.